CompanyGraph
What stands out
- Valued far above the size of its business
At a glance
- Depends onMidstream position: 5 outgoing, 6 incoming connections
- ScaleMarket cap is $11.17B, above the global median of $1.18B
- Interpretations5 currently firing — 5
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
What stands out
- Valued far above the size of its business
Financials view
Market Capitalization
11.17BUSDvs all stocks (USD)
Revenue (TTM)
616.91MUSDvs all stocks (USD)
Profit Margin
-12.18%vs Health Information Services peers
Beta
2.08xvs all stocks
52-Week Change
680.40%vs all stocks
Market Capitalization
11.17BUSDvs all stocks (USD)
Enterprise Value
10.69BUSDvs all stocks (USD)
Forward P/E
779.18xvs Health Information Services peers
Price to Sales (TTM)
18.10xvs Health Information Services peers
Price to Book (MRQ)
13.53xvs Health Information Services peers
Enterprise to Revenue
17.34xvs Health Information Services peers
Gross Margin
74.48%vs Health Information Services peers
Profit Margin
-12.18%vs Health Information Services peers
Operating Margin
-15.20%vs Health Information Services peers
Return on Assets (TTM)
-5.05%vs Health Information Services peers
Return on Equity (TTM)
-9.40%vs Health Information Services peers
Revenue (TTM)
616.91MUSDvs all stocks (USD)
Revenue per Share (TTM)
4.83USDUpdated Sep 28, 2026Quarterly Revenue Growth
-12.70%vs Health Information Services peers
Gross Profit (TTM)
432.53MUSDvs all stocks (USD)
EBITDA (TTM)
-41.20MUSDvs all stocks (USD)
Net Income (TTM)
-75.13MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
-12.65%vs Health Information Services peers
Operating Cash Flow (TTM)
127.08MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
179.66MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Sep 28, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Health Information Services peers
Revenue
642.82MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
198.94MUSDFY2025 · Dec 31, 2025Gross Profit
443.88MUSDFY2025 · Dec 31, 2025Operating Income
-110.89MUSDvs all stocks (USD)
Pre-tax Income
-39.91MUSDFY2025 · Dec 31, 2025Income Tax Expense
3.64MUSDFY2025 · Dec 31, 2025Net Income
-43.54MUSDFY2025 · Dec 31, 2025EBIT
-39.91MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
-45.99MUSDFY2025 · Dec 31, 2025Research & Development
238.63MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
316.13MUSDFY2025 · Dec 31, 2025Non-operating Interest Income
20.05MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
0.00USDFY2025 · Dec 31, 2025EPS (Basic)
-0.3500USDFY2025 · Dec 31, 2025EPS (Diluted)
-0.3500USDFY2025 · Dec 31, 2025Basic Shares Outstanding
124.75MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
124.75MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-43.54MUSDFY2025 · Dec 31, 2025Operating Cash Flow
141.48MUSDFY2025 · Dec 31, 2025Free Cash Flow
135.54MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
473.97MUSDFY2025 · Dec 31, 2025Income Tax Paid
2.39MUSDFY2025 · Dec 31, 2025Interest Paid
0.00USDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-43.54MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
43.82MUSDFY2025 · Dec 31, 2025Stock-based Compensation
109.12MUSDFY2025 · Dec 31, 2025Other Non-cash Items
-346.00KUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
6.44MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
-2.13MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
28.12MUSDFY2025 · Dec 31, 2025Capital Expenditures
-5.93MUSDFY2025 · Dec 31, 2025Net Intangibles (CF)
0.00USDFY2025 · Dec 31, 2025Purchase of Investments
-123.44MUSDFY2025 · Dec 31, 2025Sale of Investments
125.20MUSDFY2025 · Dec 31, 2025Other Investing Activity
-9.27MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-13.44MUSDFY2025 · Dec 31, 2025Shares Outstanding
130.28MSharesUpdated Sep 28, 2026Float Shares
118.19MSharesUpdated Sep 28, 2026Shares Short
16.69MSharesUpdated Sep 28, 2026Short Ratio
6.17daysvs all stocks
Short % of Shares Outstanding
18.79%vs all stocks
% Held by Insiders
1.46%vs all stocks
% Held by Institutions
120.20%vs all stocks
Total Cash (MRQ)
552.03MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
4.24USDUpdated Sep 28, 2026Total Debt (MRQ)
78.80MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.0954xvs Health Information Services peers
Current Ratio (MRQ)
5.69xvs Health Information Services peers
Book Value per Share (MRQ)
6.34USDUpdated Sep 28, 2026Total Assets
1.04BUSDvs all stocks (USD)
Total Current Assets
684.45MUSDFY2025 · Dec 31, 2025Total Liabilities
245.04MUSDFY2025 · Dec 31, 2025Total Non-current Assets
356.91MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
91.58MUSDFY2025 · Dec 31, 2025Total Current Liabilities
153.45MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
473.97MUSDFY2025 · Dec 31, 2025Other Short-term Investments
49.44MUSDFY2025 · Dec 31, 2025Accounts Receivable
47.01MUSDFY2025 · Dec 31, 2025Inventory
56.34MUSDFY2025 · Dec 31, 2025Accounts Payable
12.73MUSDFY2025 · Dec 31, 2025Short-term Debt
10.98MUSDFY2025 · Dec 31, 2025Deferred Revenue
23.90MUSDFY2025 · Dec 31, 2025Other Current Liabilities
41.06MUSDFY2025 · Dec 31, 2025Long-term Debt
73.38MUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
7.71MUSDFY2025 · Dec 31, 2025Common Stock (Book)
2.00KUSDFY2025 · Dec 31, 2025Retained Earnings
-1.51BUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
796.33MUSDvs all stocks (USD)
52-Week Low
11.16USDUpdated Sep 28, 202652-Week High
89.86USDUpdated Sep 28, 202652-Week Change
680.40%vs all stocks
Beta
2.08xvs all stocks
50-Day MA
60.37USDUpdated Sep 28, 2026200-Day MA
32.91USDUpdated Sep 28, 2026Avg 10-Day Volume
3.37MSharesUpdated Sep 28, 2026Avg 30-Day Volume
2.87MSharesUpdated Sep 28, 2026Diluted EPS (TTM)
-0.6000USDUpdated Sep 28, 2026Other Income / Expense
50.93MUSDFY2025 · Dec 31, 20255 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Cash Elevated Relative to Current Liabilities and Total Assets
Its cash covers more of its near-term bills than in its industry, and is a large share of everything it owns.
Reads
Liquidity Ratios Elevated
It can cover near-term bills from cash alone, not just from inventory.
Reads
Low-Leverage Liquidity Configuration
Cash on hand covers most or all of its debt, and its equity share of assets is high for its industry.
Reads
How does this company use capital?
Cash-Flow Ratios Elevated
More of its sales turn into cash than in its industry, and less of that cash is consumed by reinvestment than at most of its peers.
Reads
FCF Ratios Elevated
Its free cash flow is large next to assets and equity, and more of its operating cash reaches it than in its industry.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Valued far above the size of its businessSignificant
Price-to-Sales: 18.10Revenue Growth YoY: -0.13
High gross margins eroded by operating costsNotable
Gross Margin: 0.74Profit Margin: -0.12
Supply Chain
Midstream position: 5 outgoing, 6 incoming connectionsNotable
Outgoing: 5.00Incoming: 6.00
High connectivity hub: 11 industry connectionsNotable
Total Connections: 11.00
Scale
Market cap is $11.17B, above the global median of $1.18BNotable
Market cap (USD): 11,167,256,009Global Median: 1,180,223,658.953
Revenue is $616.91M, above the global median of $548.88MNotable
Revenue (USD): 616,910,976Global Median: 548,883,780.48
Levered free cash flow is $179.66M, above the global median of $18.73MNotable
Levered free cash flow (USD): 179,656,000Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Pro Medicus Limited
Tier 1ProductionRecurring-Revenue Lock-InFlowInterface
SenseTime Group Inc.
Tier 1ProductionRecurring-Revenue Lock-InInterfaceSenseMaking
GUIDEWIRE SOFTWARE INC
Tier 1ProductionRecurring-Revenue Lock-InInterfaceSenseMaking
Manhattan Associates Inc.
Tier 1ProductionRecurring-Revenue Lock-InFlowSenseMaking
Bentley Systems, Incorporated Class B
Tier 1ProductionRecurring-Revenue Lock-InSenseMakingInterface
360 Security Technology Inc.
Tier 1ProductionRecurring-Revenue Lock-InRuleInterface
Elastic N.V.
Tier 1ProductionRecurring-Revenue Lock-InFlowSenseMaking
MiniMax Group Inc
Tier 1ProductionRecurring-Revenue Lock-InSenseMakingInterface
Horizon Robotics Inc.
Tier 1ProductionRecurring-Revenue Lock-InInterfaceSenseMaking
PTC Inc.
Tier 1ProductionRecurring-Revenue Lock-InSenseMakingInterface
Companies that share active interpretations — structural patterns currently present in both stocks.
Suzhou Novoprotein Scientific Co., Ltd.
2 interpretationsLiquidity Ratios ElevatedLow-Leverage Liquidity Configuration
Horizon Fixture Group Co., Ltd.
1 interpretationFCF Ratios Elevated
Apogee Therapeutics Inc.
2 interpretationsLiquidity Ratios ElevatedLow-Leverage Liquidity Configuration